| Serial Number | 87817056 |
| Word Mark | BIOSHIN |
| Filing Date | Thursday, March 1, 2018 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, March 22, 2022 |
| Registration Number | 6679806 |
| Registration Date | Tuesday, March 22, 2022 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 1, 2018 |
| Goods and Services | Medicated and pharmaceutical preparations, both prescription and over-the-counter, for use in connection with humans and animals, namely, for the treatment of central nervous system disorders, neurologic illnesses, and psychiatric illnesses; pharmaceutical preparations for the treatment of brain ischemia; pharmaceutical preparations for the treatment of brain ischemia, namely, post-stroke recovery, severe intracranial atherosclerosis, carotid endarterectomy, cardiac bypass, cerebral vasculitis, reversible cerebral vasoconstriction syndrome; pharmaceutical preparations for the treatment of brain and cord injuries; pharmaceutical preparations for the treatment of brain and cord injuries, namely, post- intracranial hemorrhage recovery, traumatic brain injury, spinal cord injury; pharmaceutical preparations for the treatment of neurodegenerative diseases; pharmaceutical preparations for the treatment of neurodegenerative diseases, namely, Alzheimer's disease (AD), Amyotrophic Lateral Sclerosis (ALS), Huntington's disease, Lewy body dementia, frontotemporal dementia, vascular dementia, Parkinson's disease, cognitive impairment of aging, progressive Multiple Sclerosis; pharmaceutical preparations for the treatment of optic and retinal neuropathies; pharmaceutical preparations for the treatment of optic and retinal neuropathies, namely, glaucoma, diabetic retinopathy, ischemic optic and retinal neuropathies; pharmaceutical preparations for the treatment of pain; pharmaceutical preparations for the treatment of pain, namely, opioid sparing analgesia, cancer pain, chronic neuropathic pain, peripheral neuropathy, low back pain in the nature of failed back surgery syndrome, radiculopathy in the nature of sciatica, diabetic peripheral neuropathy, post-herpetic neuralgia, chemotherapy induced neuropathy and other medication induced neuropathies, complex regional pain syndrome, fibromyalgia, chronic post-operative pain, cluster thoracotomy, phantom limb, stump neuroma; pharmaceutical preparations for the treatment of headache and facial pain, namely, headache, migraine, chronic daily headache, cluster headache, trigeminal neuralgia; pharmaceutical preparations for symptomatic treatments of degenerative diseases; pharmaceutical preparations for symptomatic treatments of degenerative diseases, namely, breath holding in Rett syndrome, dystonias, dysphagia, gait abnormalities, bulbar function in ALS, pseudobulbar affect, levodopa-induced dyskinesias in Parkinson's disease, agitation in AD, disinhibition in dementia; pharmaceutical preparations for the treatment of epilepsy; pharmaceutical preparations for the treatment of epilepsy, namely, precision medicine - adjuvant for genetic epilepsy due to NMDA receptor mutations with hyperactivation; pharmaceutical preparations for the treatment of neuropsychiatric disorders; pharmaceutical preparations for the treatment of neuropsychiatric disorders, namely, treatment resistant depression, Post Traumatic Stress Disorder (PTSD) in the nature of hyperarousal, substance abuse disorders, addiction disorders, Obsessive Compulsive Disorder (OCD), hoarding, trichotillomania, eating disorders, Generalized Anxiety Disorder (GAD), adjustment disorders, panic disorder, major depressive episode, bipolar disorder in the nature of manic and depressive episodes, dysthymia, cyclothymia, psychotic disorders, schizophrenia; pharmaceutical preparations for the treatment of cerebellar disorders; pharmaceutical preparations for the treatment of cerebellar disorders, namely, spinocerebellar ataxia, Friedriech's ataxia, multisystem atrophy, essential tremor; pharmaceutical preparations for the treatment of hearing disorders, tinnitus, delirium, sleep disorders, parasomnias, learning disorders, Attention Deficit Disorder (ADD), Pervasive Developmental Disorders (PDD), Asperger's syndrome, autism, menopausal hot flashes; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of cancer, namely, monotherapy and adjunctive use |
| Pseudo Mark | BIO SHIN |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, March 8, 2018 |
| Primary Code | 005 |
| First Use Anywhere Date | Saturday, June 19, 2021 |
| First Use In Commerce Date | Saturday, June 19, 2021 |
| Party Name | BIOHAVEN THERAPEUTICS LTD. |
| Party Type | 31 - New Owner After Registration |
| Legal Entity Type | 99 - Other |
| Address | Road Town, Tortola VG1110 VG |
| Party Name | Biohaven Pharmaceutical Holding CompanyLimited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | New Haven, CT 06510 |
| Party Name | Biohaven Pharmaceutical Holding CompanyLimited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | New Haven, CT 06510 |
| Party Name | Biohaven Pharmaceutical Holding CompanyLimited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | New Haven, CT 06510 |
| Event Date | Event Description |
| Monday, April 17, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, April 17, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, April 17, 2023 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Monday, April 17, 2023 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Monday, April 17, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, January 11, 2023 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Tuesday, March 22, 2022 | REGISTERED-PRINCIPAL REGISTER |
| Saturday, February 12, 2022 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
| Friday, February 11, 2022 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
| Thursday, February 3, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, February 3, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, February 3, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, August 4, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, August 4, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, August 4, 2021 | SU - NON-FINAL ACTION - WRITTEN |
| Sunday, June 27, 2021 | STATEMENT OF USE PROCESSING COMPLETE |
| Thursday, June 24, 2021 | USE AMENDMENT FILED |
| Thursday, June 24, 2021 | TEAS STATEMENT OF USE RECEIVED |
| Thursday, December 24, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Wednesday, December 23, 2020 | SOU EXTENSION 5 GRANTED |
| Monday, December 21, 2020 | SOU EXTENSION 5 FILED |
| Monday, December 21, 2020 | TEAS EXTENSION RECEIVED |
| Wednesday, July 1, 2020 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, June 30, 2020 | SOU EXTENSION 4 GRANTED |
| Wednesday, June 17, 2020 | SOU EXTENSION 4 FILED |
| Tuesday, June 30, 2020 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, June 17, 2020 | TEAS EXTENSION RECEIVED |
| Saturday, December 21, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, December 19, 2019 | SOU EXTENSION 3 GRANTED |
| Thursday, December 19, 2019 | SOU EXTENSION 3 FILED |
| Thursday, December 19, 2019 | TEAS EXTENSION RECEIVED |
| Wednesday, October 23, 2019 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, October 23, 2019 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, June 25, 2019 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, June 21, 2019 | SOU EXTENSION 2 GRANTED |
| Friday, June 21, 2019 | SOU EXTENSION 2 FILED |
| Friday, June 21, 2019 | TEAS EXTENSION RECEIVED |
| Wednesday, September 12, 2018 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, September 10, 2018 | SOU EXTENSION 1 GRANTED |
| Monday, September 10, 2018 | SOU EXTENSION 1 FILED |
| Monday, September 10, 2018 | TEAS EXTENSION RECEIVED |
| Tuesday, June 26, 2018 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, May 1, 2018 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, May 1, 2018 | PUBLISHED FOR OPPOSITION |
| Wednesday, April 11, 2018 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, March 27, 2018 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, March 27, 2018 | ASSIGNED TO EXAMINER |
| Thursday, March 8, 2018 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, March 5, 2018 | NEW APPLICATION ENTERED |